Induction chemotherapy plus nimotuzumab followed by concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma

INTRODUCTION: This study investigated the best mode for the application of nimotuzumab (Nimo) in combination with chemoradiotherapy to treat nasopharyngeal carcinoma (NPC). MATERIAL AND METHODS: Data were prospectively collected from 168 patients with NPC from September 2009 to February 2014. One hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Xinmao, Wang, Shengzi, Li, Ji, Yan, Li, Chen, Fu, Wang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425246/
https://www.ncbi.nlm.nih.gov/pubmed/34522261
http://dx.doi.org/10.5114/aoms.2019.86712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425246/
https://www.ncbi.nlm.nih.gov/pubmed/34522261
http://dx.doi.org/10.5114/aoms.2019.86712

Ejemplares similares